Dextera Surgical, a manufacturer of a maneuverable articulating surgical stapling platform for minimally invasive surgery, has announced the enrolment of the first US patient in the MicroCutter Assisted Thoracic Surgery Hemostasis (MATCH) Registry.
MATCH is a prospective, open-label, multi-centre registry enrolling up to 120 patients undergoing lung resections in which surgical stapling is required.
This registry will analyse the effectiveness of the MicroCutter 5/80 surgical stapler for hemostasis (stopping the flow of blood) and the procedure enabling aspects of the device in lobectomy or segmentectomy lung surgery procedures using a several minimally invasive techniques including video assisted thoracic surgery (VATS) and robotic assisted surgeries as well as in open surgery.
University of Texas MD Anderson Cancer Center professor David Rice said: “The MATCH Registry will provide important clinical data regarding the hemostasis performance of the MicroCutter 5/80 while capturing video evidence of the ability of the device to navigate in tight spaces to enable less-invasive methods for treating patients undergoing lung surgery.
“We are proud to be working with these surgical pioneers at leading institutions to gather important clinical data on the MicroCutter 5/80 and its utility in thoracic surgery procedures,” said Julian Nikolchev, president and CEO, Dextera Surgical.
Leading centres in the US will take part in the MATCH Registry, including the Mayo Clinic at Rochester, Minnesota, where the first US MATCH patient was enrolled.
Further, ten patients have already been enrolled internationally at the James Cook University Hospital at Middlesbrough, the UK.
Other leading research institutions to participate in the MATCH Registry include University of Alabama at Birmingham, the University of Texas MD Anderson Cancer Center, and the Royal Infirmary in Edinburgh, Scotland, as well as several additional international sites.
MicroCutter 5/80 Stapler is only five-millimeter surgical stapler that articulates to 80 degrees in each direction.
It is manufactured and cleared for use in the US for transection and resection in multiple open or minimally invasive urologic, thoracic and pediatric surgical procedures, besides application for transection, resection and/or creation of anastomoses in the small and large intestine, and the transection of the appendix.
The MicroCutter 30 White Reload has application in vascular tissue.